About the Vistara Test
Single Gene NIPT
Vistara looks for small DNA changes, or single-gene mutations, that could affect a baby’s health. Like other non-invasive prenatal tests (NIPTs), Vistara analyses DNA from the placenta that is found in a mother’s blood.
The test:
- screens for serious genetic conditions (caused by single-gene mutations across 30 genes) that affect quality of life and may benefit from medical and/or surgical intervention
- screens for a set of disorders that, combined, occur more frequently than Down Syndrome
- screens for conditions not covered by traditional NIPTs or carrier screening
- is a simple blood test and can be performed as early as nine weeks into your pregnancy
- poses no miscarriage risk to your baby.
Screened conditions for Vistara include:
- Noonan Syndrome
- Achondroplasia
- Osteogenesis Imperfecta
- Rett Syndrome
- 21 other single-gene disorders across 30 genes
Consider Vistara for the following indications:
- paternal age (over 40 years)
- if you’d like to know as much as possible or as an extra to your Panorama Test, CVS or amniocentesis
- if ultrasound anomalies are identified on your scan (such as shortened long bones, increased NT measurements or cardiac defects)
